Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants.
Durrmeyer X, Hummler H, Sanchez-Luna M, Carnielli VP, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Mercier JC, Marlow N, Johnson S, Baldassarre J; European Union Nitric Oxide Study Group. Durrmeyer X, et al. Among authors: van overmeire b. Pediatrics. 2013 Sep;132(3):e695-703. doi: 10.1542/peds.2013-0007. Epub 2013 Aug 12. Pediatrics. 2013. PMID: 23940237 Clinical Trial.
Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.
Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Baldassarre J; EUNO Study Group. Mercier JC, et al. Among authors: van overmeire b. Lancet. 2010 Jul 31;376(9738):346-54. doi: 10.1016/S0140-6736(10)60664-2. Epub 2010 Jul 23. Lancet. 2010. PMID: 20655106 Clinical Trial.
Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial.
Greenough A, Decobert F, Field D, Hallman M, Hummler HD, Jonsson B, Sánchez Luna M, Van Overmeire B, Carnielli VP, Potenziano JL, Mercier JC. Greenough A, et al. Among authors: van overmeire b. J Perinat Med. 2020 Sep 7;49(1):104-110. doi: 10.1515/jpm-2020-0164. J Perinat Med. 2020. PMID: 32892178 Free article. Clinical Trial.
The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium.
Vanhaesebrouck P, Allegaert K, Bottu J, Debauche C, Devlieger H, Docx M, François A, Haumont D, Lombet J, Rigo J, Smets K, Vanherreweghe I, Van Overmeire B, Van Reempts P; Extremely Preterm Infants in Belgium Study Group. Vanhaesebrouck P, et al. Among authors: van overmeire b, van reempts p. Pediatrics. 2004 Sep;114(3):663-75. doi: 10.1542/peds.2003-0903-L. Pediatrics. 2004. PMID: 15342837
Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
Hundscheid T, Onland W, van Overmeire B, Dijk P, van Kaam AHLC, Dijkman KP, Kooi EMW, Villamor E, Kroon AA, Visser R, Vijlbrief DC, de Tollenaer SM, Cools F, van Laere D, Johansson AB, Hocq C, Zecic A, Adang E, Donders R, de Vries W, van Heijst AFJ, de Boode WP. Hundscheid T, et al. Among authors: van heijst afj, van overmeire b, van laere d, van kaam ahlc. BMC Pediatr. 2018 Aug 4;18(1):262. doi: 10.1186/s12887-018-1215-7. BMC Pediatr. 2018. PMID: 30077184 Free PMC article.
Topical use of nitroglycerin ointment in neonates.
van Reempts P, Van Overmeire B. van Reempts P, et al. Among authors: van overmeire b. J Pediatr. 1990 Jan;116(1):155. doi: 10.1016/s0022-3476(05)81671-3. J Pediatr. 1990. PMID: 2104927 No abstract available.
A pseudoepidemic of adenoviruses in a neonatal care unit.
Ieven M, Van Reempts P, Van Overmeire B, Provinciael D, Vael K, Pattyn S. Ieven M, et al. Among authors: van overmeire b, van reempts p. Diagn Microbiol Infect Dis. 1994 Mar;18(3):157-9. doi: 10.1016/0732-8893(94)90085-x. Diagn Microbiol Infect Dis. 1994. PMID: 7924207
74 results